THANK YOU Philanthropy fuels innovation at the University of Colorado Anschutz Medical Campus, and your giving is transforming the treatment options available to individuals with urologic cancers. New and innovative treatments are changing lives and improving outcomes. We are creating a future in which a cancer diagnosis is no longer a life-altering prospect — a future in which targeted therapies are effective the first time, giving the gift of time to our patients. Thank you for joining us on this journey.
Revolutionizing medical care for cancer
Researchers at the CU Anschutz Medical Campus are dedicated to rewriting the rules of medicine. Under the umbrella of personalized medicine, our treatment options are becoming more precise and effective by harnessing genetic data. Because of the dedication of our physician-researchers, the medicine of tomorrow will far exceed our current expectations. Momentum is on our side, and we have the top talent and stateof-the-art facilities to stake our claim at the forefront of innovation. This
PAUL MARONI, MD
innovation translates into improved patient outcomes.
New treatment options for prostate cancer
Dr. Paul Maroni’s research interests include pioneering new treatment options for patients with urologic cancers and developing new, less-invasive surgery techniques for patients with prostate cancer. Along with his research partners, Dr. Maroni has developed specialized robotic surgery techniques to
IN 7 MEN minimize the recovery time1associated with WILL surgeriesBE that DIAGNOSED would otherwise
WITH
PROSTATE CANCER DURING HIStimes LIFETIME be fairly invasive. These new treatment options are speeding recovery and getting people back to healthy lives quicker than before.
161,000+
Collaborating throughout the University of Colorado Anschutz Medical Campus
Dr. Maroni collaborates with several researchers at the CU Anschutz Medical
NEW
Campus including Rajesh Agarwal, PhD, in the CU Skaggs School of
MD from University of Illinois College of Medicine Joined CU in 2007 as Associate Professor of
CASES OF PROSTATE Pharmacy and Pharmaceutical Sciences. Dr. Agarwal is a national leader CANCER IN 2017
Surgery
seed extract, phytic acid and bitter melon and the role they may play in
Doc recognition in 5280
researching the molecules inside natural products such as milk thistle, grape fighting cancer.
PROSTATE
CANCER IS THE
3RD
2014, 2015 and 2016 Top
LEADING CAUSE OF CANCER DEATH IN AMERICAN MEN